Research
Molecular
Semaglutide has a later pooled time-to-onset median of GADRs compared to liraglutide (7 days vs 4 days).
Healthcare providers should be aware of the delayed onset of gastrointestinal issues with semaglutide.
StrongSupportsmedium confidence
semaglutide had... later pooled time-to-onset median of GADRs compared with those of liraglutide (7 days... vs 4 days)
Why this rating
Based on the analysis of real-world data from a pharmacovigilance database.
Source
Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study
Yu Zhou et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2022
other · n=6222Cited 15×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →